(2S,3aS,4S,5R,7R,8S,8aS,9R)-Octahydro-2,8a-dihydroxy-4,8,9-trimethyl-1-oxo-5-(2,3,5,8-tetrahydro-1,3-dioxo-2-phenyl-1H-[1,2,4]triazolo[1,2-a]pyridazin-6-yl)-1H-3a,8-propanoazulen-7-yl 2-chloroacetate

Request For Quotation
(2S,3aS,4S,5R,7R,8S,8aS,9R)-Octahydro-2,8a-dihydroxy-4,8,9-trimethyl-1-oxo-5-(2,3,5,8-tetrahydro-1,3-dioxo-2-phenyl-1H-[1,2,4]triazolo[1,2-a]pyridazin-6-yl)-1H-3a,8-propanoazulen-7-yl 2-chloroacetate Basic information
Product Name:(2S,3aS,4S,5R,7R,8S,8aS,9R)-Octahydro-2,8a-dihydroxy-4,8,9-trimethyl-1-oxo-5-(2,3,5,8-tetrahydro-1,3-dioxo-2-phenyl-1H-[1,2,4]triazolo[1,2-a]pyridazin-6-yl)-1H-3a,8-propanoazulen-7-yl 2-chloroacetate
Synonyms:(2S,3aS,4S,5R,7R,8S,8aS,9R)-Octahydro-2,8a-dihydroxy-4,8,9-trimethyl-1-oxo-5-(2,3,5,8-tetrahydro-1,3-dioxo-2-phenyl-1H-[1,2,4]triazolo[1,2-a]pyridazin-6-yl)-1H-3a,8-propanoazulen-7-yl 2-chloroacetate;Ferroptocide
CAS:2505218-38-0
MF:C30H36ClN3O7
MW:586.08
EINECS:
Product Categories:
Mol File:2505218-38-0.mol
(2S,3aS,4S,5R,7R,8S,8aS,9R)-Octahydro-2,8a-dihydroxy-4,8,9-trimethyl-1-oxo-5-(2,3,5,8-tetrahydro-1,3-dioxo-2-phenyl-1H-[1,2,4]triazolo[1,2-a]pyridazin-6-yl)-1H-3a,8-propanoazulen-7-yl 2-chloroacetate Structure
(2S,3aS,4S,5R,7R,8S,8aS,9R)-Octahydro-2,8a-dihydroxy-4,8,9-trimethyl-1-oxo-5-(2,3,5,8-tetrahydro-1,3-dioxo-2-phenyl-1H-[1,2,4]triazolo[1,2-a]pyridazin-6-yl)-1H-3a,8-propanoazulen-7-yl 2-chloroacetate Chemical Properties
Boiling point 695.2±65.0 °C(Predicted)
density 1.45±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)
solubility DMSO: Soluble
Methanol: Soluble
pka11.97±0.70(Predicted)
Safety Information
MSDS Information
(2S,3aS,4S,5R,7R,8S,8aS,9R)-Octahydro-2,8a-dihydroxy-4,8,9-trimethyl-1-oxo-5-(2,3,5,8-tetrahydro-1,3-dioxo-2-phenyl-1H-[1,2,4]triazolo[1,2-a]pyridazin-6-yl)-1H-3a,8-propanoazulen-7-yl 2-chloroacetate Usage And Synthesis
UsesFerroptocide is a cell death inducer that triggers ferroptosis and has anti-tumor activity. Ferroptocide can induce oxidative stress, leading to G2/M cell cycle arrest and apoptosis activation in LNCaP cells, while also effectively inhibiting the cell viability of both LNCaP and TRAMP-C1 cells. Ferroptocide can be used to study its capability to induce mitochondrial autophagy and to trigger immunogenic cell death (ICD) in prostate cancer cells[1].
References[1] Hillary Shah, et al. Evaluation of Ferroptocide (FTC) As a Potential Immunogenic Cell Death Inducing Agent in Prostate Cancer Cells. Biochemistry and Molecular Biology. 2021.35.S1.03356.
[2] EVIJOLA LLABANI. Diverse compounds from pleuromutilin lead to a thioredoxin inhibitor and inducer of ferroptosis[J]. Nature chemistry, 2019, 11 6: 521-532. DOI: 10.1038/s41557-019-0261-6
(2S,3aS,4S,5R,7R,8S,8aS,9R)-Octahydro-2,8a-dihydroxy-4,8,9-trimethyl-1-oxo-5-(2,3,5,8-tetrahydro-1,3-dioxo-2-phenyl-1H-[1,2,4]triazolo[1,2-a]pyridazin-6-yl)-1H-3a,8-propanoazulen-7-yl 2-chloroacetate Preparation Products And Raw materials
Tag:(2S,3aS,4S,5R,7R,8S,8aS,9R)-Octahydro-2,8a-dihydroxy-4,8,9-trimethyl-1-oxo-5-(2,3,5,8-tetrahydro-1,3-dioxo-2-phenyl-1H-[1,2,4]triazolo[1,2-a]pyridazin-6-yl)-1H-3a,8-propanoazulen-7-yl 2-chloroacetate(2505218-38-0) Related Product Information
GPX4-IN-13 N-(4-chlorophenyl)-5-nitrofuran-2-carboxamide TRi-1 RSL3 Auranofin Erastin